Presidential Document2022-19282
National Ovarian Cancer Awareness Month, 2022
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 6, 2022
Signed
August 31, 2022
Issuing agencies
Executive Office of the President
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 171 (Tuesday, September 6, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 171 (Tuesday, September 6, 2022)]
[Presidential Documents]
[Pages 54299-54300]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-19282]
Presidential Documents
Federal Register / Vol. 87, No. 171 / Tuesday, September 6, 2022 /
Presidential Documents
[[Page 54299]]
Proclamation 10433 of August 31, 2022
National Ovarian Cancer Awareness Month, 2022
By the President of the United States of America
A Proclamation
This year, nearly 20,000 women in the United States
will be diagnosed with ovarian cancer. Hard to detect
and frequently discovered in advanced stages, this
disease is often deadly for so many. Structural
barriers inhibit access to quality and affordable
health care, and documented disparities in treatment
can lead to higher mortality rates for Black women and
elderly women in particular. During Ovarian Cancer
Awareness Month, our Nation honors those who are
struggling with this dreaded disease, remembers the
loved ones we have lost, and recommits to ending
ovarian cancer--and all cancer--as we know it.
This issue is personal to me and the First Lady, as it
is for so many families. Earlier this year, we
reignited the Cancer Moonshot Initiative which I
oversaw in 2016. The Cancer Moonshot Initiative has a
goal of cutting the cancer death rate in half--at
least--over the next 25 years. My Administration also
created, and the Congress has funded, the Advanced
Research Projects Agency for Health (ARPA-H) at the
National Institutes of Health to revolutionize the way
we detect and treat diseases like cancer, Alzheimer's,
and diabetes. With improved screening and early
detection technologies, diagnostics, treatments, and
supportive care, we are on the cusp of real
breakthroughs. The incidence of ovarian cancer has
decreased over the last decades as survival rates have
increased.
Of course, there is more work to do. I promised to
protect and build on the Affordable Care Act (ACA), and
that is exactly what my Administration will do--
including by guaranteeing protections for women with
preexisting conditions and preventing insurance
companies from dropping patients with ovarian cancer.
The ACA covers visits to a primary care physician and
gynecologist without copayments or deductibles, which
can lead to earlier detection of ovarian cancer. We
must also increase diversity in clinical trials to
ensure that new treatments will work for everyone and
to better understand why ovarian cancer impacts some
Americans more than others. My Administration will
continue supporting the National Institutes of Health,
the Food and Drug Administration, and other agencies as
they broaden outreach to racial and ethnic minority
populations and other underrepresented groups and
assess whether cancer treatments will be effective for
the diverse range of patients who need them.
Expanding access to care is especially critical as we
emerge from the COVID-19 pandemic. In the early days of
the pandemic, Americans missed almost 10 million cancer
screenings. Medical experts in my Administration and
around the country encourage women to reschedule these
appointments as soon as possible. Additionally, the
Centers for Disease Control and Prevention's (CDC)
``Inside Knowledge about Gynecologic Cancer'' website
is a useful resource for information on ovarian cancer.
For people who think they may be at risk for this
disease, experts have compiled helpful information
about ovarian cancer at <a href="http://cancer.gov/types/ovarianandcdc.gov/cancer">cancer.gov/types/ovarianandcdc.gov/cancer</a>. Being informed is a first
step toward prevention.
As we observe National Ovarian Cancer month, we will
never forget those we have lost. We honor our health
care experts who work tirelessly to
[[Page 54300]]
save lives. And we offer strength to women and families
across this country fighting ovarian cancer today and
in the future.
NOW, THEREFORE, I, JOSEPH R. BIDEN JR., President of
the United States of America, by virtue of the
authority vested in me by the Constitution and the laws
of the United States, do hereby proclaim September 2022
as National Ovarian Cancer Awareness Month. I call upon
the people of the United States to speak with their
doctors and health care providers to learn more about
ovarian cancer. I encourage citizens, government
agencies, private businesses, nonprofit organizations,
the media, and other interested groups to increase
awareness of what Americans can do to detect and treat
ovarian cancer.
IN WITNESS WHEREOF, I have hereunto set my hand this
thirty-first day of August, in the year of our Lord two
thousand twenty-two, and of the Independence of the
United States of America the two hundred and forty-
seventh.
<GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT>
(Presidential Sig.)
[FR Doc. 2022-19282
Filed 9-2-22; 8:45 am]
Billing code 3395-F2-P
</pre></body>
</html>Indexed from Federal Register on September 6, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.